Skip to main content

Conditions

Estrogen dominance

estrogen excess

Estrogen dominance is a condition Ray Peat identified as the biochemical and tissue-level equivalent of aging itself, driven by an absolute excess of estrogen or a deficiency of its opposing hormones. Peat argued that the fibrotic changes, accelerated accumulation of age…

10 passages
2 authors
1997–2022
Most-cited: Ray Peat

Estrogen dominance is a condition Ray Peat identified as the biochemical and tissue-level equivalent of aging itself, driven by an absolute excess of estrogen or a deficiency of its opposing hormones. Peat argued that the fibrotic changes, accelerated accumulation of age pigment, and degenerative organ changes seen in aging are identical to the effects produced by estrogenic excess, a perspective confirmed by later measurements showing that the ratio of estrogen to antiestrogens increases with age in both sexes, including humans. This state is not confined to women; Peat noted that old men typically have more estrogen than women because their testosterone is being massively converted to estrogen by aromatase as they age. The condition creates a self-reinforcing vicious circle: excess estrogen blocks thyroid secretion, and the resulting hypothyroidism impairs the liver's ability to inactivate estrogen, allowing it to accumulate to even higher levels.

The systemic effects of estrogen dominance stem from its fundamental action on cellular energetics. Estrogen acts as an excitatory agent, temporarily increasing alertness by acting on the same enzymes as cocaine, but this excitation is ultimately excitotoxic to nerves, leading to conditions like epilepsy and chorea. At the cellular level, this unsustainable excitation causes oxygen deficiency, leading the cell to take up water, which makes blood vessels leaky and forces the adrenal cortex to compensate by increasing sodium retention, potentially shifting a person from low blood pressure and edema to high blood pressure. In the heart, estrogen exerts a negative inotropic and lusitropic action, decreasing the muscle's pumping strength and its ability to fully relax, a state analogous to diastolic heart failure. Peat emphasized that a tiny, uninterrupted dose of estrogen was shown to produce cancer in every tissue, whereas periodic interruption with progesterone was profoundly protective.

The liver is the primary organ for detoxifying estrogen, a process that requires adequate thyroid hormone, protein, and B vitamins to function. When functioning correctly, the liver inactivates estrogen for secretion, but hypothyroidism—often caused by stress, protein deficiency, or diets high in unsaturated fats and goitrogenic vegetables—cripples this process. Progesterone is the central antagonist to estrogen dominance, and Peat detailed its multi-faceted anti-estrogen actions: it inhibits the aromatase enzyme that produces estrogen, inactivates estrogen receptors, and promotes the addition of glucuronic and sulfuric acid to the estrogen molecule, detoxifying it directly within the cell before it even enters the bloodstream. Because stress activates the estrogen receptor and diverts the precursor pregnenolone toward cortisol production, a stressed state inherently bypasses progesterone synthesis, deepening the dominance of estrogen.

The clinical manifestations of estrogen dominance are extensive and often misattributed. Peat linked it directly to the development of cystic ovaries, prostate enlargement and cancer in testosterone-deficient men, and the soft tissue calcification seen in scleroderma, which he observed could reverse rapidly upon cessation of estrogen supplementation. Contrary to the claim that estrogen prevents osteoporosis, Peat cited evidence that estrogen causes calcium retention in soft tissues, not bones, and that the appearance of increased bone density on x-ray tests is an artifact of estrogen altering the fat and water content of tissues. He argued that estrogen actually promotes bone loss through its synergy with prolactin, serotonin, and parathyroid hormone. The water retention, gynecomastia, and abdominal fat accumulation seen in aging males are outward expressions of this underlying hormonal imbalance. Danny Roddy has extended this framework by noting that the stress conditions often assumed to cause an estrogen deficiency—such as low-carb dieting, over-exercise, and hypothyroidism—actually increase tissue estrogen levels because prostaglandins synthesized from released free fatty acids activate aromatase.

The therapeutic approach to estrogen dominance centers on restoring oxidative metabolism and directly opposing estrogen's effects. Because thyroid function is essential for liver detoxification of estrogen and for the synthesis of progesterone from cholesterol, normalizing thyroid function is often the foundational step to bring estrogen levels down. Progesterone can break the vicious cycle, even in a single dose, by blocking estrogen's effects and allowing a return to a more normal temperature set point, simultaneously lowering stress hormones like adrenaline and cortisol. Peat also identified that eliminating polyunsaturated fats is crucial, as they are the substrate for the cyclooxygenase enzyme that produces the prostaglandins which keep aromatase active, creating a local inflammatory loop that sustains estrogen production in stressed tissues.

People also ask

Related concepts

Analytics and on-error session replay stay off until you accept. See our Privacy Policy.